Premium
Urinary excretion of valproate metabolites in children and adolescents
Author(s) -
Reith David M.,
Andrews Jaymie,
ParkerScott Suzie,
Eadie Mervyn J.
Publication year - 2000
Publication title -
biopharmaceutics and drug disposition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.419
H-Index - 58
eISSN - 1099-081X
pISSN - 0142-2782
DOI - 10.1002/bdd.247
Subject(s) - valproic acid , urine , glucuronide , anticonvulsant , medicine , urinary system , metabolite , lamotrigine , pharmacology , epilepsy , psychiatry
The objective of this communication is to describe the changes in the metabolic profile of valproic acid (VPA) from early to late childhood and adolescence. A cross‐sectional study of 12 children and adolescents attending a neurological outpatients department, who were medicated with VPA, was carried out. The proportions of daily dose excreted as VPA‐glucuronide, 3‐oxo‐VPA and 4‐OH‐VPA were calculated by relating 24‐h recovery of these metabolites from urine to daily VPA dose. VPA, 3‐oxo‐VPA and 2‐en‐valproic acid (2‐en‐VPA) were measured in trough serum samples. VPA and its metabolites were measured using a capillary gas chromatograpy method. The proportion of daily dose recovered as VPA‐glucuronide in children 10 years and younger was smaller than in older children ( p <0.05). There were no differences between age groups in the recovery of the other measured metabolites. Lamotrigine (LTG) comedication was also associated with a higher proportion of VPA dose recovered as glucuronide ( p <0.01). LTG comedication had a stronger association with a higher proportion of dose being recovered as VPA‐glucuronide on multivariate analysis than did the age group ( p =0.001 versus p <0.05). In conclusion, older children and adolescents, when compared with younger children, and those comedicated with LTG excrete a higher proportion of VPA dose as VPA‐glucuronide. Copyright © 2000 John Wiley & Sons, Ltd.